Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3V Vĕtvicka, W Reed, M L Hoover, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complementM E Medof, D M Lublin, V M Holers, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNAM L Tykocinski, H K Shu, D J Ayers, et al.
Immunopharmacology|July 17, 1999
Therapeutic intervention with complement and beta-glucan in cancerG D Ross, V Vetvicka, J Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1997
Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18)V Vetvicka, B P Thornton, T J Wieman, et al.
Blood|November 1, 1976
Surface markers of human eosinophilsS Gupta, G D Ross, R A Good, et al.
Investigative Ophthalmology & Visual Science|June 1, 1990
Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal glandJ H Lass, E I Walter, T E Burris, et al.
The Journal of Clinical Investigation|August 1, 1988
Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3B L Myones, J G Dalzell, N Hogg, et al.
The Journal of Clinical Investigation|November 1, 1978
Surface markers of complement receptor lymphocytesG D Ross, R J Winchester, E M Rabellino, et al.
Pageof 18